FDA Inspection
MSD Ireland (Carlow)MSD Ireland (Carlow) – FDA Inspection, Feb 21, 2017
Record Details
This FDA Inspection record concerns MSD Ireland (Carlow), with an inspection on February 21, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · b1e5bb59-3ee9-4fd6-bb83-71bea7188de0
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1004674
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.113(b)Validation lacking for sterile drug products
Full citation text and observation details available on the Dashboard.
Other FDA inspections of MSD Ireland (Carlow)
6| Date | Classification | Office | Project area |
|---|---|---|---|
| April 1, 2025 | Not classified | Office of Inspections and Investigations | Vaccine, Allergenic, and Live Biotherapeutic Products |
| May 28, 2024 | Not classified | Office of Inspections and Investigations | |
| April 21, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 7, 2022 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| November 22, 2019 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
Other documents for MSD Ireland (Carlow)
- FDA Inspection 1266301 - 2025-04-01
- FDA Inspection 1239350 - 2024-05-28
- FDA Inspection 1230982 - 2023-04-21
- FDA Inspection 1171315 - 2022-06-07
- FDA Inspection 1110715 - 2019-11-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.